Primary objective is to analyse whether transnasal videolaryngoscopy in outpatient practice is more accurate in determination of the extend of the affected mucosa of laryngopharyngeal tumours compared to direct laryngoscopy under general anaesthesia…
ID
Source
Brief title
Condition
- Other condition
- Respiratory and mediastinal neoplasms malignant and unspecified
Synonym
Health condition
premaligne en maligne tumoren van de larynx en farynx
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameters are the assessment of the extend of mucosal pathology
by video recordings of High Definition videolaryngoscopy compared with that by
rigid direct laryngoscopy using a standard format for judgement of tumour
extension.
Secondary outcome
Secondary study parameters are: date of first contact, standardized judgment of
fiberoptic and videolaryngoscopy compared to HD videolaryngoscopy and direct
laryngoscopy, standardized judgment of first videolaryngoscopy 2-3 weeks
earlier and comparison with study videolaryngoscopy, date of laryngoscopy in
general anaesthesia, date of start of treatment and time till start of
treatment, follow up time, recurrence rate and date of recurrence, patients
quality of life and voice handicap, and costs of diagnostic route.
Background summary
Major improvements have been made in flexible endoscopic tools for the
assessment of mucosal and submucosal lesions in the upper aerodigestive tract.
In the past decade several types of transnasal video endoscopes have been
developed that are being used increasingly in otorhinolaryngology. These
videolaryngoscopes show tremendous increase in visibility of detail compared to
the ordinary used transnasal fiberoptic laryngoscope. And in the laryngoscopes
with an instrument channel it is also possible to obtain tissue for
histopathologic investigation. However, due to lack of evidence on the accuracy
of these videolaryngoscopes, direct laryngoscopy under general anaesthesia has
remained the gold standard for determination of the extend of laryngeal and
pharyngeal lesions suspect for carcinoma and to perform biopsy.
In this study we will analyse the accuracy of new endoscopic methods in the
detection and determination of the extend of laryngeal and pharyngeal
epithelial lesions. If this method is proven accurate, direct laryngoscopy
under general anaesthesia may no longer be needed in the routine diagnostic
work-up. It will obviate the need for pre-operative consultation of
anaesthesiologists, the risks of general anaesthesia in patients with often
significant comorbidity and possible delays in treatment. More timely treatment
is likely to result in a reduction of duration of uncertainty and anxiety for
the patient. Lastly, it may decrease health care costs and improve outcome.
The endoscopes included in this study are all flexible transnasal
laryngoscopes. Each of them is CE marked and currently used in daily practice
in Radboud University Nijmegen Medical Centre. The fiberoptic laryngoscope,
videolaryngoscope with i-scan filter and high definition (HD) videolaryngoscope
with i-scan filter [Pentax, Japan] are included. A videolaryngoscope with a
working channel will not be used, therewithal strict disinfestations and
sterilization methods the risk of infection is negligible. I-scan is a
postprocessing digital image enhancement with adjustable tonal, contrast and
surface filters with the intent to increase visibility and differentiation of
pathologic mucosa. In gastroenterology a prospective randomized control trial
has shown significant higher detection of neoplastic lesions and more flat
benign tumours when using a HD colonoscope with i-scan function compared to
standard video colonoscopy [Hoffman et al, 2010].
Study objective
Primary objective is to analyse whether transnasal videolaryngoscopy in
outpatient practice is more accurate in determination of the extend of the
affected mucosa of laryngopharyngeal tumours compared to direct laryngoscopy
under general anaesthesia; the current gold standard.
Secondary objectives are multiple:
• To study whether transnasal videolaryngoscopy in outpatient practice is more
accurate in determination of the extend of the affected mucosa of
laryngopharyngeal tumours compared to transnasal fiberoptic laryngoscopy.
• To assess tumour growth during waiting times for completion of the diagnostic
phase by standardized judgment of first videolaryngoscopy approximately 2-3
weeks earlier and comparison with study videolaryngoscopy.
• To determine the recurrence rate in relation to the possibly more adequate
delineation of the lesions with the use of transnasal videolaryngoscopy and the
early detection of recurrence during follow up.
• To compare cost-effectiveness of transnasal videolaryngoscopy in outpatient
practice to direct laryngoscopy under general anaesthesia.
• To ascertain patient general and disease-specific quality of life and voice
handicap index.
Study design
Study design will be a prospective descriptive study.
Study burden and risks
Patients participating in this study get an extra opportunity to see video
images of the tumour without any additional risk caused by the two extra
transnasal laryngoscopies. Furthermore, the two quality of life questionnaires
are short and don*t contain detailed intimated personal questions. Potential
additional tiny (2-3 millimeters) biopsies, during rigid laryngoscopy in
general anesthesia based on videolaryngoscopic image with or without i-scan
filters of suspected tumour extension, are harmless and may be of great
interest in precise tumour delineation and staging, and therefore accurate
treatment. There are no extra visits necessary for study participation.
If videolaryngoscopy is proven to be accurate, the need for direct laryngoscopy
under general anaesthesia is obviated and thereby the need for pre-operative
consultation of anaesthesiologists, the risks of general anaesthesia in
patients with often significant comorbidity and possible delay in treatment.
More timely treatment is likely to result in a reduction of the duration of
uncertainty and anxiety for the patient. Lastly, it may decrease health care
costs and improve outcome.
Edith Piafstraat 30
Lent 6663MA
NL
Edith Piafstraat 30
Lent 6663MA
NL
Listed location countries
Age
Inclusion criteria
All patients presented with laryngeal or pharyngeal tumours suspect for malignancy or proven to be malignant in Radboud University Nijmegen Medical Centre or Medical Centre Leeuwarden are eligible for inclusion.
Exclusion criteria
Age younger than 18 years old
Inability to undergo generals anaesthesia
Metal incompetence
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL41474.091.13 |